Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$266.92
Market Cap
15.89B
Sector
Health Care
Div. Growth
-
P/E
158.0
P/B
9.65
P/S
30.42
Dividend %
-
P/CF
90.4
P/FCF
353.8
Op. Cash Flow
83.3K
FCF
0.8
Op. Margin
24.20%
Net Margin
19.70%
ROE
6.90%
ROI
4.00%
ROA
5.50%
EPS Growth
211.10%
Current Ratio
2.8
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Concert Pharmaceuticals Inc (CNCE) $2.88 - - 105.2M Strong Buy
Capital Senior Living Corporat (CSU) $30.91 - - 77.2M Strong Buy
Lantheus Holdings Inc (LNTH) $23.26 - - 1.74B Strong Buy
Recro Pharma Inc (REPH) $1.85 - - 95.8M Strong Buy
Castlight Health Inc (CSLT) $1.68 - - 251.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More